HeXun Biosciences Co., Ltd.
Research HeXun Biosciences Co., Ltd. (6986.TWO) on Bullrun: market cap TWD 2.33B, P/E 17.8, dividend yield 0.5%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker6986.TWO
- ExchangeTWO
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyTWD
- Market capTWD 2.33B
- P/E17.8
- Dividend yield0.5%
- Financial periodQ2 2026
- RevenueTWD 93.86M
- Net incomeTWD 38.37M
- Free cash flowTWD 34.13M
- Gross margin95.9%
Valuation Snapshot
latest market cap is TWD 2.33B; P/E is 17.8; dividend yield is 0.5%.
Peer valuation comparison
Latest P/E is 17.83x versus a Healthcare sector median of 21.8x (18.2% below).
Latest dividend yield is 0.52% versus a Healthcare sector median of 2.4% (78.3% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | TWD 2.33B | 17.8 | 0.4% | 0.19 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.19 TWD, yield 0.5%.
About HeXun Biosciences Co., Ltd.
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan. It provides contract manufacturing; commissioned inspection; aseptic filling; and consulting services. The company was founded in 2019 and is based in Taoyuan City, Taiwan.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is HeXun Biosciences Co., Ltd.'s market cap?
HeXun Biosciences Co., Ltd.'s market capitalization is TWD 2.33B.
What is HeXun Biosciences Co., Ltd.'s P/E ratio?
HeXun Biosciences Co., Ltd.'s price-to-earnings (P/E) ratio is 17.8.
Does HeXun Biosciences Co., Ltd. pay a dividend?
HeXun Biosciences Co., Ltd. has a dividend yield of 0.5%.
What does HeXun Biosciences Co., Ltd. do?
HeXun Biosciences Co., Ltd. engages in the research and development of stem cell drug development and cardiovascular disease treatments in Taiwan. It provides contract manufacturing; commissioned inspection; aseptic filling; and consulting services. The company was founded in 2019 and is based in Taoyuan City, Taiwan.